Ibrahim Elbagory

1.1k citations
28 papers · 793 indexed · h-index 15
Topics
Advanced Drug Delivery Systems (12 papers)Drug Solubulity and Delivery Systems (10 papers)Pharmaceutical studies and practices (4 papers)

In The Last Decade

Ibrahim Elbagory

27 papers receiving 759 citations

Peers

Ibrahim Elbagory
Comparison fields: 5 of 115
  • Pharmaceutical Science 322
  • Molecular Biology 170
  • Biomaterials 163
  • Biomedical Engineering 119
  • Materials Chemistry 118
Replace Jaymin C. Shah with:
Jaymin C. Shah United States
Subramanian Natesan India
Gyiae Yun South Korea
Bader B. Alsulays Saudi Arabia
Sergio Cafaggi Italy
F. Kedzierewicz France
Dinesh Jain India
Young‐Guk Na South Korea
Magda W. Samaha Egypt
Sanaa A. El‐Gizawy Egypt
Ibrahim Elbagory relative to Jaymin C. Shah United States Jaymin C. Shah's profile →
Citations per field
00.5×3.7×
Jaymin C. Shah · 1×
Citations per year

Countries citing papers authored by Ibrahim Elbagory

Since Specialization
Citations

This map shows the geographic impact of Ibrahim Elbagory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim Elbagory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim Elbagory more than expected).

Fields of papers citing papers by Ibrahim Elbagory

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ibrahim Elbagory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim Elbagory. The network helps show where Ibrahim Elbagory may publish in the future.

Co-authorship network of co-authors of Ibrahim Elbagory

This figure shows the co-authorship network connecting the top 25 collaborators of Ibrahim Elbagory. A scholar is included among the top collaborators of Ibrahim Elbagory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ibrahim Elbagory. Ibrahim Elbagory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 34
3 0
4 12
5 19
6 20
7 40
8 31
9
EFFECTS OF SPHERE SIZE, POLYMER TO DRUG RATIO AND PLASTICIZER CONCENTRATION ON THE RELEASE OF THEOPHYLLINE FROM ETHYLCELLULOSE MICROSPHERES
3
10
Formulation and in vivo evaluation of diclofenac sodium sustained release matrix tablet: effect of compression force.
1
11 43
12 47
13 21
14 148
15 8
16 51
17 27
18 27
19 4
20 8

About Ibrahim Elbagory

Ibrahim Elbagory is a scholar working on Pharmaceutical Science, Molecular Medicine and Biochemistry, having authored 28 papers that have together received 793 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (12 papers), Drug Solubulity and Delivery Systems (10 papers) and Pharmaceutical studies and practices (4 papers). The work is most often cited by research in Pharmaceutical Science (322 citations), Biomaterials (163 citations) and Molecular Medicine (43 citations). Ibrahim Elbagory has collaborated with scholars based in Saudi Arabia, Egypt and United Kingdom. Frequent co-authors include Mohsen A. Bayomi, Ehab I. Taha, Nahla S. Barakat, Alanood S. Almurshedi, Ibrahim A. Alsarra, Alaa Eldeen B. Yassin, Mounir M. Salem‐Bekhit, Md. Khalid Anwer, Mohammed M. Ghoneim and Sultan Alshehri. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Molecular Liquids and Polymers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026